These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29668951)

  • 21. An open study of inactivated hepatitis A vaccine (VAQTA) in Taiwanese healthy adult volunteers: safety, tolerability, and immunogenicity.
    Yang CY; Lu CY; Lee CY; Shao PL; Wang CY; Wu TZ; Huang LM
    J Microbiol Immunol Infect; 2004 Aug; 37(4):216-8. PubMed ID: 15340648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
    Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
    J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
    Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
    Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A.
    Zuckerman JN; Kirkpatrick CT; Huang M
    J Travel Med; 1998 Mar; 5(1):18-22. PubMed ID: 9772311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents.
    Yoon SH; Kim HW; Ahn JG; Kim IT; Kim JH; Kong KA; Kim KH
    J Korean Med Sci; 2016 Jan; 31(1):73-9. PubMed ID: 26770041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
    Li RC; Li Y; Yi N; Huang L; Wan Z; Zhang Y; Rasuli A
    Pediatr Infect Dis J; 2013 Feb; 32(2):e77-81. PubMed ID: 23334341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine.
    Zamir C; Rishpon S; Zamir D; Leventhal A; Rimon N; Ben-Porath E
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):185-7. PubMed ID: 11347668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Serologic Follow-up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered With Routine Childhood Vaccines at 12-15 Months of Age.
    Dagan R; Ashkenazi S; Livni G; Go O; Bagchi P; Sarnecki M
    Pediatr Infect Dis J; 2016 Jul; 35(7):e220-8. PubMed ID: 27093164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single dose.
    Zhang X; An J; Tu A; Liang X; Cui F; Zheng H; Tang Y; Liu J; Wang X; Zhang N; Li H
    Hum Vaccin Immunother; 2016 Sep; 12(9):2322-6. PubMed ID: 27494260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study.
    Luo J; Wang X; Ma F; Kang G; Ding Z; Ye C; Pan Y; Zhao Y; Hong S; Chen J; Xi J; Wen S; Lin Y; Li X; Qiu L; Yang X; Li G; Yang J; Sun Q
    Clin Microbiol Infect; 2019 Nov; 25(11):1422-1427. PubMed ID: 30496870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety and immunogenicity of a new inactivated hepatitis A vaccine].
    Ren A; Ma J; Feng F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):357-9. PubMed ID: 11986726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.
    Wallace MR; Brandt CJ; Earhart KC; Kuter BJ; Grosso AD; Lakkis H; Tasker SA
    Clin Infect Dis; 2004 Oct; 39(8):1207-13. PubMed ID: 15486846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice.
    Neukam K; Delgado Fernández M; Hernández Quero J; Rivero-Juárez A; Llaves-Flores S; Jiménez Oñate F; Gutiérrez-Valencia A; Espinosa N; Viciana P; López-Cortés LF
    J Acquir Immune Defic Syndr; 2019 May; 81(1):e1-e5. PubMed ID: 30865187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term immunity after two doses of inactivated hepatitis A vaccine, in Argentinean children.
    López EL; Contrini MM; Mistchenko A; Debbag R
    Pediatr Infect Dis J; 2010 Jun; 29(6):568-70. PubMed ID: 20195189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with hepatitis A virus infection among HIV-positive patients before and after implementation of a hepatitis A virus vaccination program at a medical centre in central Taiwan.
    Lin JJ; Lee YT; Yang HJ
    Sex Health; 2020 Jun; 17(3):239-246. PubMed ID: 32571474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.
    André F; Van Damme P; Safary A; Banatvala J
    Expert Rev Vaccines; 2002 Jun; 1(1):9-23. PubMed ID: 12908508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA) in adults: safety, tolerability, and immunogenicity.
    Linglöf T; van Hattum J; Kaplan KM; Corrigan J; Duval I; Jensen E; Kuter B
    Vaccine; 2001 Jul; 19(28-29):3968-71. PubMed ID: 11427272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.